Drug Profile
Chlamydia trachomatis vaccine - Maxim
Latest Information Update: 02 Nov 2001
Price :
$50
*
At a glance
- Originator SBL Vaccin AB
- Developer Maxim Pharmaceuticals
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 02 Nov 2001 Discontinued-Preclinical for Chlamydial infections in USA (Unknown route)
- 16 Jun 2001 No-Development-Reported for Chlamydial infections in USA (Unknown route)
- 29 Aug 1996 Preclinical development for Chlamydial infections in USA (Unknown route)